PreveCeutical Medical (PRVCF) Stock Price, News & Analysis

Company Overview

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: $0.01 to $0.03
• Volume: 500 shs
• Average Volume: 100,415 shs
• Market Capitalization: $15.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PRVCF Stock Analysis - Frequently Asked Questions

How have PRVCF shares performed this year?

PreveCeutical Medical's stock was trading at $0.0184 at the start of the year. Since then, PRVCF stock has increased by 45.7% and is now trading at $0.0268.
View the best growth stocks for 2025 here.

How do I buy shares of PreveCeutical Medical?

Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PRVCF
• CIK: N/A
• Web: www.preveceutical.com
• Phone: (604) 416-7777
• Fax: 778-945-6290
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$940 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -544.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -2.68

Miscellaneous

• Outstanding Shares: 563,370,000
• Free Float: N/A
• Market Cap: $15.10 million
• Optionable: Not Optionable
• Beta: 0.43